Your browser doesn't support javascript.
loading
Factors Affecting SARS-CoV-2 Vaccination Intent and Decision Making Among African American, Native American, and Hispanic Participants in a Qualitative Study.
Schwartz, Benjamin; Brewer, Janesse; Budigan, Haley; Bernier, Roger; Dudley, Matthew Z; Kan, Lilly; Proveaux, Tina M; Roberts, Robin; Tafoya, Nadine; Hamlin, Mary Davis; Moore, Lucy; Hughes, Michael; Turner, Brian; Al-Dahir, Sara; Velasco, Elizabeth; Privor-Dumm, Lois; Veloz, Wendie; White, Jennifer A; Dubois, Shantel; Ooton, Jenn; Kipp, Billie Jo; Show, Ty J; Salu, Kemi; Chavez, Brisa; Montes, Maria Del Pilar; Najera, Rene; King, Terris; Salmon, Daniel A.
Afiliación
  • Schwartz B; Fairfax County Health Department, Fairfax, VA, USA.
  • Brewer J; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Budigan H; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Bernier R; Retired, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Dudley MZ; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Kan L; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Proveaux TM; National Association of County and City Health Officials, Washington, DC, USA.
  • Roberts R; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Tafoya N; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Hamlin MD; Perdido, LLC, Alexandria, VA, USA.
  • Moore L; Nadine Tafoya and Associates, Fresno, CA, USA.
  • Hughes M; Aspen Trees Consulting, Charlottesville, VA, USA.
  • Turner B; Lucy Moore Associates, Santa Fe, NM, USA.
  • Al-Dahir S; Hughes Collaboration, Denver, CO, USA.
  • Velasco E; Department of Psychology and African American Diaspora Studies Program, Xavier University of Louisiana, New Orleans, LA, USA.
  • Privor-Dumm L; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Veloz W; College of Pharmacy, Xavier University of Louisiana, New Orleans, LA, USA.
  • White JA; Velasco's Enterprises Limited, El Paso, TX, USA.
  • Dubois S; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Ooton J; Harris County Public Health, Houston, TX, USA.
  • Kipp BJ; Horizon Foundation, Columbia, MD, USA.
  • Show TJ; Spirit Lake Tribe, Fort Totten, ND, USA.
  • Salu K; City of Glenwood Springs, Glenwood Springs, CO, USA.
  • Chavez B; Native Americans in Philanthropy, Washington, DC, USA.
  • Montes MDP; Blackfeet Tribe, Browning, MT, USA.
  • Najera R; Harris County Public Health, Houston, TX, USA.
  • King T; Garfield County Public Health, Glenwood Springs, CO, USA.
  • Salmon DA; Private practice, Houston, TX, USA.
Public Health Rep ; 138(3): 422-427, 2023.
Article en En | MEDLINE | ID: mdl-36971286
Limited studies are available on how decisions and perceptions on SARS-CoV-2 vaccination have changed since the start of vaccination availability. We performed a qualitative study to identify factors critical to SARS-CoV-2 vaccination decision making and how perspectives evolved among African American/Black, Native American, and Hispanic communities disproportionately affected by COVID-19 and social and economic disadvantage. We conducted 16 virtual meetings, with 232 participants in wave 1 meetings (December 2020) and with 206 returning participants in wave 2 meetings (January and February 2021). Wave 1 vaccine concerns in all communities included information needs, vaccine safety, and speed of vaccine development. Lack of trust in government and the pharmaceutical industry was influential, particularly among African American/Black and Native American participants. Participants showed more willingness to get vaccinated at wave 2 than at wave 1, indicating that many of their information needs had been addressed. Hesitancy remained greater among African American/Black and Native American participants than among Hispanic participants. Participants in all groups indicated that conversations tailored to their community and with those most trustworthy to them would be helpful. To overcome vaccine hesitancy, we propose a model of fully considered SARS-CoV-2 vaccine decision making, whereby public health departments supply information, align with community values and recognize lived experiences, offer support for decision making, and make vaccination easy and convenient.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toma de Decisiones / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Public Health Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toma de Decisiones / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Public Health Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos